- We are exhibiting at Linus Dagarna together with EMM Life Science AB (LinkedIN)
VΓ€xjΓΆ, September 19-21, 2023
- We closed our first investment round and raised 7M SEK! πππ
The investors include ALMI Invest, together with life science angel investors and the Propel Capital. More information can be found in our press releases. (English – Swedish)
May 24, 2023
- We presented results of our clinical performance study at Karolinska University Hospital at ECCMID 2023 (here)
- 22 new companies of Sting are announced in Dagens Industri and UTI-lizer is one of them!
September 7, 2022
- We got support from Vinnova! πππ
Our preparatory project for international proposal is accepted. We will be setting a multi-center clinical trial for our tests at the point-of-care.
June 13, 2022
- We successfully completed first extensive clinical validation and performance study of our tests at the Karolinska University Hospital! ππ― (post)
June 1, 2022
- UTI-lizer has joined the leading Nordic incubator Sting! π
May 1, 2022
- UTI-lizer has been selected as one of the Hello Tomorrow Deep Tech Pioneers!
September 23, 2021
- UTI-lizer got the EIT Health Wildcard! We have participated in EIT Health Wildcard Hackathon.
July 1-10, 2020